Internal Medicine, Gastroenterology · Ocean Springs, MS
NPI
1700885746
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
3890 Bienville Blvd
Ocean Springs, MS, 39564
Phone (228) 872-6291
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
2,149 services
Medicare patients, 2024
837
Average age 73
Drug cost, 2024
$2.1M
8,669 prescriptions
Company payments, 2025
$1,701
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfred E McNair Jr. was code 99214 (office e&m - established), 559 times for 319 patients. In total Alfred E McNair Jr. billed 2,149 services in 53 codes, and Medicare paid $186K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 559 | 319 | $84.52 | $47K |
| 43239 Upper GI Endoscopy | Facility | 460 | 421 | $51.32 | $24K |
| 45380 Lower GI Endoscopy - Other | Facility | 300 | 295 | $128.20 | $38K |
| 43248 Upper GI Endoscopy | Facility | 193 | 177 | $105.01 | $20K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 89 | 39 | $49.14 | $4,373 |
| 45378 Lower GI Endoscopy - Other | Facility | 54 | 54 | $133.59 | $7,214 |
| 45381 Lower GI Endoscopy - Other | Facility | 49 | 47 | $15.32 | $750 |
| 45385 Colonoscopy - Lesion Removal | Facility | 46 | 43 | $197.18 | $9,070 |
| 43235 Upper GI Endoscopy | Facility | 35 | 35 | $84.95 | $2,973 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 35 | 35 | $178.63 | $6,252 |
| 99204 Office E&M - New | Office | 29 | 29 | $107.76 | $3,125 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 15 | $62.52 | $1,813 |
| 87077 Bacterial Culture | Office | 26 | 26 | $7.31 | $190 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 16 | 11 | $37.38 | $598 |
| 43251 Upper GI Endoscopy | Facility | 16 | 16 | $148.08 | $2,369 |
By year: 2022 $213K for 3,597 services; 2023 $172K for 2,441 services; 2024 $186K for 2,149 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87077 Bacterial Culture | 26 | 26 | $7.31 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Alfred E McNair Jr. prescribed most often to Medicare patients was Famotidine, with 1,774 prescriptions and refills. In total Alfred E McNair Jr. wrote 8,669 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 1,774 | 4,909 | 722 | $20K |
| Sucralfate Generic | 1,121 | 2,013 | 438 | $385K |
| Esomeprazole Magnesium Generic | 818 | 1,902 | 316 | $42K |
| Omeprazole Generic | 555 | 1,463 | 268 | $10K |
| Baclofen Generic | 499 | 1,338 | 233 | $4,927 |
| Pantoprazole Sodium Generic | 365 | 965 | 157 | $5,893 |
| Linzess Linaclotide | 325 | 617 | 127 | $323K |
| Dicyclomine Hcl Generic | 264 | 358 | 127 | $5,701 |
| Metoclopramide Hcl Generic | 173 | 217 | 61 | $885 |
| Ciprofloxacin Hcl Generic | 170 | 170 | 152 | $990 |
| Creon Lipase/Protease/Amylase | 152 | 210 | 54 | $267K |
| Dexlansoprazole Dr Dexlansoprazole | 150 | 337 | 54 | $56K |
| Fluconazole Generic | 147 | 147 | 102 | $1,376 |
| Alprazolam Generic | 137 | 145 | 21 | $543 |
| Colestipol Hcl Generic | 114 | 213 | 48 | $15K |
Brand drugs: 1,118 claims; generic drugs: 7,539 claims; opioid claims: 118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfred E McNair Jr. $1,701 ($1,701 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $455.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $455 |
| Aimmune Therapeutics, Inc. | 10 | $283 |
| Genzyme Corporation SNY | 11 | $211 |
| Janssen Biotech, Inc. JNJ | 5 | $137 |
| Ardelyx, Inc. ARDX | 3 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $80.69 |
| Novo Nordisk Inc NVO | 2 | $72.9 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $58.22 |
| Gilead Sciences, Inc. GILD | 3 | $48.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.